<html xmlns="http://www.w3.org/1999/xhtml"><head>
        <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <meta name="viewport" content="width=device-width, height=device-height, initial-scale=0.5, minimum-scale=0.5, user-scalable=yes, maximum-scale=2.0, target-densitydpi=device-dpi" />
				<meta name="robots" content="all"/>
        <meta name="description" content="description">
        <meta name="keywords" content="">
        <title>Page 341 - MIMS April 2020 E4</title>
<style type="text/css">
<!--
body {
	margin-left: 0px;
	margin-top: 0px;
	margin-right: 0px;
	margin-bottom: 0px;
}
  
#container {margin:50px auto;padding:0px;width:910px;}
#left-button{ width:90px; height:100%;float:left }
#middle{ width:730px; margin:0px; float: left;}
#right-button{ width:90px; float:left;}
html, body, div, ul, li, dl, dt, dd, h1, h2, h3, h4, h5, h6, form, input, dd,select, button, textarea, iframe, table, th, td { margin: 0; padding: 0; }
img { border: 0 none; displayblock}
span,ul,li,image{ padding:0px; margin:0px; list-style:none;}
#top-title{ width:714px; margin-bottom:10px; float:left; padding:0px 8px}
#top-title2{ width:320px;  float:right;}
#content{ width: 730px; float:left;float:left;word-wrap: break-word;}
#content-top{ width:730px; background-image:url(images/top_bg.jpg); height:56px; background-repeat:no-repeat; float:left;}
#content-top1{ width:70%; padding:16px 0px 0px 30px; font-family:Arial, Helvetica, sans-serif; font-size:24px; color:#636363;float:left;}
#content-top2{ width:60px; float:right; padding:25px 30px 0px 0px;font-family:Arial, Helvetica, sans-serif; font-size:11px; color:#2f2f2f; font-weight:bold; text-align:right}
#content-middle{ width:730px; background-image:url(images/middle_bg.jpg); background-repeat:repeat-y;float:left;}
#content-middle1{ width:475px; padding:25px 0px 25px 35px; font-family:Arial, Helvetica, sans-serif; font-size:12px; color:#636363; line-height:150%;float:left;}
#content-middle2{  padding:7px; float:right; margin:25px 35px 0px 0px; border:solid 1px #c8c8c9; background-color:#FFF; text-align:center}
#content-bottom{ width:730px; background-image:url(images/bottom_bg.jpg); background-repeat:no-repeat; height:58px;float:left;}
#content-bottom2{ width:110px; height:42px; margin:0px auto; padding-top:4px;}
#input{ width:58px; height:20px; background-color:#FFF; border:solid 1px #dfdfe0; color:#636363; text-align:center; font-size:11px;}
.font1{ font-family:Arial, Helvetica, sans-serif; font-size:10px; color:#2f2f2f;}
.font1 a:link{
	text-decoration: none;
    color:#2f2f2f;

}
.font1 a:visited{
	text-decoration: none;
    color:#2f2f2f;
	
}
.font1 a:hover{
	color: #2f2f2f;
	text-decoration: underline;

}



.text-container {
padding: 20px;
color: #333;
margin-top: 24px;
line-height: 22px;
border-top-left-radius: 3px;
border-top-right-radius: 3px;
}

.use-as-video {
float: right;
padding-left: 20px;
}
.cc-float-fix:before, .cc-float-fix:after {
content: "";
line-height: 0;
height: 0;
width: 0;
display: block;
visibility: hidden;
}
.use-as-video-img {
cursor: pointer;
position: relative;
width: 320px;
height: 180px;
}
.use-as-video-title {
font-size: 15px;
font-weight: bold;
color: #000000;
padding-bottom: 5px;
}
-->
</style>
<script type="text/javascript">
<!--
function MM_preloadImages() { //v3.0
  var d=document; if(d.images){ if(!d.MM_p) d.MM_p=new Array();
    var i,j=d.MM_p.length,a=MM_preloadImages.arguments; for(i=0; i<a.length; i++)
    if (a[i].indexOf("#")!=0){ d.MM_p[j]=new Image; d.MM_p[j++].src=a[i];}}
}

function MM_swapImgRestore() { //v3.0
  var i,x,a=document.MM_sr; for(i=0;a&&i<a.length&&(x=a[i])&&x.oSrc;i++) x.src=x.oSrc;
}

function MM_findObj(n, d) { //v4.01
  var p,i,x;  if(!d) d=document; if((p=n.indexOf("?"))>0&&parent.frames.length) {
    d=parent.frames[n.substring(p+1)].document; n=n.substring(0,p);}
  if(!(x=d[n])&&d.all) x=d.all[n]; for (i=0;!x&&i<d.forms.length;i++) x=d.forms[i][n];
  for(i=0;!x&&d.layers&&i<d.layers.length;i++) x=MM_findObj(n,d.layers[i].document);
  if(!x && d.getElementById) x=d.getElementById(n); return x;
}

function MM_swapImage() { //v3.0
  var i,j=0,x,a=MM_swapImage.arguments; document.MM_sr=new Array; for(i=0;i<(a.length-2);i+=3)
   if ((x=MM_findObj(a[i]))!=null){document.MM_sr[j++]=x; if(!x.oSrc) x.oSrc=x.src; x.src=a[i+2];}
}
//-->
</script>
</head>

<body onload="MM_preloadImages('images/next2.png','images/previous2.png')">
<div id="container">
<div id="left-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page340.html"><img src="images/previous_big.png" width="90" height="80" /></a></p>
</div>
<div id="middle">
  <div id="top-title"><span class="font1">Basic HTML Version</span>
    <div id="top-title2">
      <table width="100%" border="0" align="right" cellpadding="0" cellspacing="0">
        <tr>
        	<td width="66%"> </td>
          <td width="35%" style="display:none" align="right"><img src="images/content.png" width="19" height="16" /></td>
          <td width="31%" style="display:none" class="font1"><a href="">Table of Contents</a></td>
          <td width="6%"><img src="images/view.png" width="19" height="16" /></td>
          <td width="28%" class="font1"><a href="../../MIMS April 2020 E4.html#p=341">View Full Version</a></td>
        </tr>
      </table>
    </div>
  </div>
  <div id="content">
     <div id="content-top">
        <div id="content-top1">Page 341 - MIMS April 2020 E4</div>
        <div id="content-top2">P. 341</div>
     </div>
     <div id="content-middle">
     	
     	  <div class="text-container">
    <div class="use-as-video cc-float-fix">
      <a style="text-decoration: none;" href="../../MIMS April 2020 E4.html#p=341"><img src="../thumb/341.jpg" /></a>
    </div>

    <p class="use-as-video-title"></p>
    <pre style="white-space:pre-line"><code>304 / 2020-04                                                      Endocrine System - 19.6.3 / 19.6.4
   bef. Primolut N 1 tab. 2-3xdly from 19th-26th day of cycle. Over   oed., hypotens., hot flushes, Cushings syndr., bone min.density loss,   epilep./diab.mellit. aggrav., limit.exper.in women old.than 65 yrs.,
   at least next 2-3 cycles admin estradiol valerate 10 mg IM on 6   th  osteoporos., osteoporot.fract., GI disturbs.  monit. of condits.pres./past/occur.dur.pregn.or prev. horm.treatm.
     th
   & 16  days of artificial cycle follow.by 1 tab 2xdly.on days 19-26.   Special precautions: Poss.drowsin.& vertigo, not recomm.in lac-  eg oestrogen-depend.breast/ uter./ovar.or liv.tumours/leiomyoma/
   Then attempt to stop estrog.& induc.cycl.bleed.with 1 tab.2xdly.  tat., pre-treatm.gynae.exam., reserv. treatm.for where corpus luteum   endometrios./ endometr.hyperplas./fibrocyst. breast dis./1  degree
                                                                                      st
   from 19-26  day of cycle.    secret.is insuffic., treatm.not contracept.  breast Ca relativ./ hypertens./ cholelithias./liv.dis./diab.mellit.with
       th
   PMT, cyclic.mastopathy: 1 tab. 2-3xdly from 19th-26th day   Drug interactions: Effic.poss.decr.by enhanc. metabol.by hepat.  vasc. involvem./migraine or sev.headaches/ otoscleros./epilep./mul-
   of cycle.                    enzyme induc.meds., effic. decr. by griseofulvin & activ.charcoal,   tiple scleros./liv.& ren. funct. disturbs./HF/porphyr., VTE risk fact.eg.
   Endometr: 1 tab 2xdly from 5th day of cycle for 4-6 mnths. Incr.to 2   incr.eff.of cyclospor./ theophyll.& troleandomycin.  fam. hist.thereof/obesity/prolong.immobilisat./ maj. trauma or surg.,
   tabs 2xdly.if spott.occurs resum. with init.dos.when bleed.ceases.   discont.immed.in jaund./liv. funct. deteriorat./ signif.BP incr./new
   Ovulat.& menstruat. do not occur.dur.treatm.  VISANNE, Bayer [P/S]  onset migraine-type headache & pregn., lact.intol.
   Menstr.timing: See lit.      Dienogest                     Interactions: Decr. eff. with cytochrome P450 enzym. such as cert.
   Contraindications: Pregn., lactat., act.thrombo-embol.process./  Indications: Endometrios.  anticonvuls./anti-infect., poss. induc. eff.with ritonavir/telaprevir/
   hist.thereof, diab.mellit.with vasc. involvem., sev.hepat.dis.pres./  (S3) TABS. 44/21.8.2/0159  nelfinavir, poss. induc.metab.with herb.preps.cont.St John’s Wort,
   hist.as long as liv. values not return.to norm., pres.liv.tumours   718451-001: 2 mg, 28, R366,22  st  poss.decr.eff.with incr.oestrad.& norethisterone acet.metabolism,
                                       st
   (benign/ malign) or hist.thereof, known/suspect. sex hormon.-  Dosage: Start 1  pack on day 1 of natur.cycle i.e.1  day of menstr.  circul.lev.incr.by drugs inhibit. hepat.microsom. metabol.enzym.
   depend.malign.               bleed. Take 1 tab./day pref.at same time dly.throughout 28 days   eg.ketoconazole.
   Side effects: Naus., headache, oed., vis disturbs., migraine, dyspn.,   without regard for bleed. Start next pack without interrupt.when
                                 st
   hypersens., chloasma         1  finish. Take one tabl.only as soon as rememb.if tab(s) miss. Con-  ANGELIQ, Bayer [P/S]
   Special precautions: Incr.thromboembol.risk, incl. poss.liv.tumour   tin.taking tab.at usual time next day. Tab.not absorb due to vomit./  Estradiol 1 mg, drospirenone 2 mg
   in different diagnost.if sev. upper abdom.complaints occur, discont.  diarrh.to be replac.by one tab.  Indications: Hormone replacem.ther.for climacter. syndr.sympts.,
   if the follow. occur: migrain.headaches/more freq. unusually sev.  Contraindications: Known/susp.pregn., lactat., act./ hist.of ven.  postmenopaus.osteoporos.risk reduct. with intact uterus.
   headaches/, sudd.percept.disords./ thrombophlebit./thromboem-  thromboembol.disord., past/pres. arter. & CV dis., diab.mellit.with   (S4) TABS, 37/21.8.2/0451
   bol.sympts./painful/tight chest/pend.ops/immobilisat./jaund./  vasc.involvem., pres./ hist. of sev.hepat.dis.as long as liv.funct. val-  703438-001: 28, R318,34
   hepatit./ gen. prurit./ signif.rise in BP & pregn., strict supervis, of   ues not return. to norm., pres./hist.of liv. tumours, known/susp.sex   Dosage: Contin.ther.pref.at same time each day. If chang.from se-
   diabet., consid.organ.cause if bleed. does not stop/heavy bleeds   horm.-depend.malign., undiagn. vag. bleed.  quent.combin.HRT start at end of sched.bleed. 1 tab dly.
   still cont.aft.init. haemorrh. arrest despite reg.tab.tak., excl.prol-  Side effects: Liv.tumours, periph.insul. resist./ gluc. tol.effs., chloas-  Contraindications: Unknown abnorm.vag. bleed., know/suspect.
   act. produc. tum.bef.treat.prim.& second.amenorrh., excl. pregn.  ma, persist.ovar.follicle, weight chang., psych.disords., libido loss,   breast Ca or hist.thereof, known/ suspect.oestrog.depend.neoplas.,
   bef. & dur.treatm., pts.with tend.to chloasma to avoid sun/UV   CNS eff., headache, migraine, dry eyes, tinnit., circulat. syst. disor-  liv.tumour pres./ hist., exist./prev.ser.hepat./ren.dis., act./hist.of
   expos., psych.depress.,      ds., palpit., hypotens., dyspn., GI disturbs. incl.gastrointest.inflamm.,   ven. thrombos., hist.of/rep.ven. thromboembol./ known thrombo-
   Interactions: Decr.effic.where sex.hormon. clear. incr.(eg many   gingivit., skin reacts. incl.pigment.disord./onychoclas./hirsutism, alo-  phil.not treat.with anticoags., sev. hypertriglyceridaem., known/
   hepat.enzyme induc drugs/ griseofulvin/ oxcarbazep & rifabut.  pec., photosens., back/bone/pelv.pain, musc. spasm, heavin./pain in   suspect.pregn., lactat.
                                extremit., UTI, breast discomf./ mass/indurat., ovar.cyst, hot flush.,   Side effects: Bleed., spott., breast/abdom.pain, extremit.pain, CV
   PROVERA, Pfizer [P/S]        uter. / vag.bleed., vag.candidias., vulvovag.dryn., genit. discharg.,   effs., GI disturbs., oed., hyperlipemia, musc.cramps, arthralg., CNS
   Medroxyprogesterone acetate.  atroph.vulvovaginit., fibrocyst.breast dis., asthen., oed., bleed.irregul.  effs., benign breast neoplasm/enlargem., alopec., skin/ hair disords.,
   Indications: Dysfunct.uterine bleed., mild to mod. endometr., op-  Special precautions: Ven.thromboembol.risk, discont. in case of   hirsutism, taste disturbs., enlarg. uter. fibroids, cervix.neoplasms,
   pose endometr.eff.of oestrog.in menopaus. women being treat.  longt. immobilisat.& do not resume treatm.unt.at least 2 wks.aft.  vulvovaginit., endometr/cervic.disords., ovar.cyst, UTI/incontin., ery-
   with oestrog., menopaus. vasomot.sympts., diagnos.of prim.&   compl. remobilisat., breast Ca risk, life-threat.intra-abdom. haem-  thema nodosum/multiforme, chloasma, haemorrhag. dermatit., leu-
   second.amenorrh.             orrh.with poss.liv.tumours, depress. hist., withdr. ther.in case of hy-  korrh., dysmenorrh., breast Ca, breast engorgem., dyspn., headache,
   (S4) TABS. G2988, Z/21.8.2/363.  pertens., discont. ther. if cholestat.jaund.recurr.&/prurit.which occur.   mood swings, hot flush., nervousn., weight gain, chills, malaise.
   757934-005: 5 mg, 30, R142,26  dur.1  pregn./prev.sex ster.use, diab.women esp. gestat.diab.mellit.  Special precautions: Compl.hist./examinat.& eval.bef.init./dur.&
                                  st
   757934-013: 5 mg, 100, R474,22  hist., avoid sun expos./ultraviol. radiat. if chloasma tenden., cons.  re-institut.ther., not a contracept., recog.ven.thromboembol.risk fact.,
   808245-007: 10 mg, 30, R245,39  benef./risk in case of extra-uter.pregn./tubul.funct.impairm. hist., bar-  no clinic.data on concom. anticoag.ther., post-op pts. where prolong.
   Dosage: Dysfunct.uterine bleed: 5-10 mg dly.from 16th-21st   rier contracept.advis., discont.ther.should pregn. occur, max.enzym.  immobilisat.likely, incr.breast Ca risk, incr.risk of endometr.Ca with
   day of cycle x5-10 days.     induct.not seen for 2-3 wks but sust.for at least 4 wks.aft.ther.stopp.  prolong. unoppos. oestrog., differ.diagn.of hepat.tumour in pres.
   Endometrios: 10 mg 3xdly from 1st day of cycle x90 days.  Interactions: CYP3A4 induc./inhibit.poss.aff. metabol., poss.reduc.  of upp.abdom.pain/enlarg.liv/intra-abdom. haemorrh. signs, gall-
   Opposit.of endometr.eff.of oestrog.in oestrog. treat.meno-  eff.with incr.sex horm.clear. due to enzym.induct., poss.incr.eff.with   bladder dis., consid.discont.in pres.of sustain.signific.hypertens.,
                   th
   paus.women: 5-10 mg/ day from 16  day of a 25 day course of   reduc. sex horm. clear.due to enzym.inhib., interacts.with meds.   theorect. hyperkalaem. risk where pre-treat.ser.K  in upper range/
                                                                                   +
   oestrog.therapy x10 days.    induc.microsom.enzym.poss.result.in incr. sex horm.clear., known   concom.K -spar.meds., monit.liv.funct.in predispos., diab., endo-
                                                                  +
   Menopaus: 10-20 mg dly.contin.  CYP3A4 inhibits.poss.incr. progestog.plasma lev.  metr.assessm.if abnorm. uter. bleed.freq./persist., incr.size of uter.
   Prim.& second.amenorrh: 5-10 mg dly x10 days.              fibroids, discont.if endometrios.reactiv., rule out prolactinoma bef.
   Contraindications: Thromboembol.disord., thrombophlebit., cere-  init.ther.is suspect., UV expos. when chloasma exper., epilep., benign
   br.apoplexy/hist.of these condits., liv.dysfunct., breast/genit.malign.,   breast dis., asthma, migraine, porphyr., otoscleros., SLE, chorea min.
   undiagn. vag.bleed., miss./incompl.abort., pregn.  19.6.4  Combinations  Interactions: Clinic.effic.reduc.by hepat.enzyme induc.meds., me-
   Side effects: Anaphylax.& anaphylact.reacts., thromboembol. phe-  tabol.inhibit.by CYP3A4 inhibit., ac. alcoh.ingest.elev.oestrad.lev.
   nom., CNS eff., urtic., prurit., oed., skin rash with/without prurit.,      (See also 17.1.1, 19.6.2, 19.6.3)
   acne, hirsut., alopec., melasma/chloasma, naus., breast tendern., ga-  ESTALIS (MDR Listing)  CLIMEN, Bayer [P/S]
   lactorrh., pyrex., weight change, moon faces, neonat.jaund., choles-  11 white tabs.estradiol-17-valerate 2 mg, 10 pink tabs.estradiol-
   tat.jaund., menstr. changes, changes in cervic.eros.& secret., neuro-  ACTIVELLE, Novo Nordisk [P/S]  17-valerate 2 mg, cyproterone acetate 1 mg, 7 non-hormonal tabs.
                                Estradiol 1 mg, norethisterone acetate 0,5 mg.
   ocul.les. Follow.reacts.in pts.receiv. oestrog. progest. combinat:incr.  Indications: Climacteric symptomat.in pts.with intact uterus, os-
   BP, backache, premenstr-like syndr., erythema multiform.& nodosum,   Indications: Vasomot.sympts.assoc.with oestrog. defic.in women   teoporos.prophylax.in postmenopaus. women.
                                with intact uterus 1 yr.aft. menopause, reduc.bone loss risk in post-
   libido & appetite changes, haemorrhag.erupt., cystit.-like syndr.  (S4) TABS, Y/21.8.2/275
   Special precautions: Discont.if there is sudden part./complete   menopaus. women.  818550-007: 28 calend.pack, R224,54
                                (S4) TABS.33/21.8.2/0532
   loss of vis., sudden onset of proptos., diplop./migraine, epilep.,   Dosage: Commen.on 5th day of cycle/in case of pts.with amen-
   asthma, card./ ren. dysfunct., diab., psych.depress., onset of cli-  881112-003: 28, R239,21  orrh (excl. pregn) & postmenopaus. women on any day take 1 tab.
                                Dosage: 1 tab dly.without interrupt.pref.at same time dly. Treatm.
   materic poss.mask., breakthrough bleed.likely when treat.for en-  dly on appropr.day.
   dometrios., advise patholog.when submitt. specimens., do not   to be initiat.1 yr.aft.menopause., switch.to high.dos.ther.if respons.  Contraindications: Pregn., lactat., sev.liv.funct. disturbs., jaund./
                                aft.3 mnths.not satisfact.,
   admin.to lactat. mothers, pretreatm.physical exam.to incl.breast/   persist.itch.dur.prev.pregn., prev. /exist.liv.,uterus, ovaries/breast
   pelvic organs & pap smear.   Contraindications: Pregn./susp.& lactat., known/ susp. /hist.of   tumours/ suspic. thereof, endometrios., prev./exist. thromboembol.
                                breast/ovary/uter./liv.tumours, estrog. depend.malign.tumours./
   Drug interactions: Aminoglutethimide depress. bioavailabil.  process., diabet.with vasc.changes, sickle-cell anaem., lipometabol.
                                susp., undiagn. genit. bleed., prev.idiopath./curr.ven. thromboem-  disturbs., herpes of pregn. hist., otoscleros.with deteriorat.dur.pregn.
   UTROGESTAN, Medi Challenge [P/S]  bol. disords./stroke/hist.of act./recent arter. thromboembol.dis., ac./  Side effects: Breast tens., intermenstr.bleed., gastr.complaints,
   Progesterone                 chron.liv.dis./hist.of, sickle cell anaem., jaund./persist.itch./herpes   body weight & libido changes, oed., headache, depress.moods,
   Indications: Adjunct.to post-menopaus.oestrog. replacem.ther., to   dur. prev. pregn., endometrios., sev.diab.mellit.with vasc. chang., lipo-  incr.freq.of no bleed. dur.tablet free interv.incr.as durat.of treatm.
   reduc.endometr.hyperplas.& Ca risk, second.amenorrh.in absenc.of   metabol.disturbs., otoscleros. with deteriorat.dur.pregn., porphyr.,  incr., liv.tumours with intra-abdom.haemorrh.
   organ. pathologies.          Side effects: Very common: Breast pain/ tendern., vag. haemorr.   Special precautions: Diabet., hypertens., varicos. veins, phlebit.
   (S4) CAPS, 29/21.8.2/0215, A40/21.8.2/0771  Common: Naus., periph. oed., genit.candidias., vaginit., incr.weight,   hist., otoscleros., multiple scleros., epilepsy, porphyria, tetany, cho-
   851957-005: 100 mg, 30, R237,06  fluid retent., back pain, headache, migraine, aggravat. of depress./   rea min., discont.in case of 1st time/more freq occurr.of migrain.
   717195-001: 200 mg, 15, R237,06  aggravat.of breast oed./ enlargem., uter. fibroids/aggravat.of/reoc-  headaches, sudden percept.disords., 1st signs of thrombophlebit.,
   Dosage: Admin.betw.meal times. Do not take miss. dos./or   curr. Uncommon: Abdom. pain/distens./discomf., flatul., bloat.,   pend.operat., immobilisat., onset of jaund /hepatit., itch of whole
   double dos.                  hypersens., leg cramps, nervousn., alopec., hirsutism, acne, prurit.,   body, incr.epilept. seiz., signific.rise in BP, pregn, rule out pregn.if no
   HRT: 200 mg dly.at night 2 hrs.aft.food, for the last 14 days of oes-  urticar., superfic.thrombo phlebit. Rare: Deep ven.thrombos, pulm.  bleed.occurs if possibil exists, investig.rep. intermenstrual bleed.
   trog.treatm./cycle where pts.prefer not to have cycl.bleed. In pts.  embol. Unknown: Benign/malign.oestrog.-depend. neoplasms eg.   Interactions: Metabol.of steroid hormon. accelerat.by var.subst.
   prefer.withdr.bleed. admin.300 mg dly.x10-12 days of oestrog.treatm.   endometr Ca, insomn., anx, libido changes, dizzin., stroke, vis.dis-  (eg.barbit, phenylbutazone, hydantoins, rifampicin), some antibiot.
   Breakthrough bleed.dur.2  wk.ther.indicat.poss. early endometr.at-  turbs., aggravat. hypertens., dyspeps., vomit., gallbladd.dis, chole-  (eg. ampicill.) reduc.subst.lev.
             nd
   rophy req.re-eval.of oestrog.dos. Endo-uter.examin.if breakthrough   lithiasis/ aggravat of/re-occurr., seborrh., rash, angioneurot.oed.,
   bleed.persists aft. oestrog.dos.adjustm. Breakthrough bleed.dur.   endometr.hyperplas., vulvovag. prurit., MI, stroke, decr.weight,   ESTALIS, (AI Pharm) Novartis [P/S] &
   1  wk. due to either sev.early endometr.atrophy/ organ.les. & en-  incr. BP, chloasma, erythema multiforme/nodosum, vasc. purpura,   Oestradiol hemihydrate, norethisterone acetate.
   st
   doscop.examinat.recomm.      probable dement.              Indications: Post-menopaus.sympt.treatm. & reduc.bone loss in
   Second.amenorrh: Dly dos.300 mg admin.as 100 mg in morn.&   Warnings and special precautions: Not indic. for coron.heart   post-menopaus.women with with intact uterus.
   200 mg at bedt.x10 days start. at any time. Withdr.bleed.occurs.  dis.prev./dur.pregn./as contracept., benef. vs HRT risk esp.longt.ther.,   (S4) TRANSDERM.PATCH, 37/21.8.2/0456
   within 8-15 days aft. treatm.init.  investig.cause of spott.if occurs. some time on ther./aft.ther. discont.,   708907-001: 50/140 µg, 8, R289,27
   Contraindications: Sev.liv.dis., all liv. complaints, undiagn.vag.  incr.gall bladd. dis.& SLE risk, incr. endometr.Ca /hyperplas./breast &   Dosage: Admin.as at low.effect.dos. Compl. current cycle if receiv.
   bleed., condits.affect.by sex.steroids., safety in pregn.not est.  ovar.Ca/VTE/ CAD/ ischaem.stroke risk relat.to longt./unoppos. oes-  sequent.oestrog./progest. bef. init.ther. Apply patch every 3-4 days
   Side effects: Menstr.irregulat., galactorrh., breast pain/tender.,   trog., incr.density of mammograph.images & poss. affect. radiologic.  dur.28 day cycle. Rotate applic.site with interv.of at least 1 wk.
   decr.libido, hyperglycaem., thromboembol./ thromb.format., adren.  detect.of breast Ca advers., discont. ther.if VTE devel., CV morbitit.  Contraindications: Known/suspect.pregn., breastfeed., undiagn.
                                    st
   suppress./ insuffic., anaphylax., CNS effs., ment.depress., unusual/   risk dur.1  year of ther., compl.med./gynae.hist./breast exam. bef.   abnorm.vag.bleed., known/ suspect./hist.of breast Ca, known/susp.
   rapid weight gain, skin reacts., loss/gain of hair, chloasma, jaund.,   init.ther.& reg.aft., monit.in card./ren. dysfunct., re-eval.in asthma/  endometr. Ca, oestrog.depend.neoplas., exist./ prev.sev.hepat.dis.,</code></pre>
     	</div>
    
     </div>
     <div id="content-bottom">
       <div id="content-bottom2">
         <table width="110" border="0" cellspacing="0" cellpadding="0">
           <tr>
             <td width="22%" height="44"><a href="page340.html"><img src="images/previous.png" width="26" height="19" id="Image2" onmouseover="MM_swapImage('Image2','','images/previous2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
             <td width="43%">
             	&nbsp;&nbsp;&nbsp;<a href="page336.html">336</a>&nbsp;&nbsp;&nbsp;<a href="page337.html">337</a>&nbsp;&nbsp;&nbsp;<a href="page338.html">338</a>&nbsp;&nbsp;&nbsp;<a href="page339.html">339</a>&nbsp;&nbsp;&nbsp;<a href="page340.html">340</a>&nbsp;&nbsp;&nbsp;<a href="page341.html">341</a>&nbsp;&nbsp;&nbsp;<a href="page342.html">342</a>&nbsp;&nbsp;&nbsp;<a href="page343.html">343</a>&nbsp;&nbsp;&nbsp;<a href="page344.html">344</a>&nbsp;&nbsp;&nbsp;<a href="page345.html">345</a>&nbsp;&nbsp;&nbsp;<a href="page346.html">346</a>
             </td>
             <td width="35%"><a href="page342.html"><img src="images/next.png" width="26" height="19" id="Image1" onmouseover="MM_swapImage('Image1','','images/next2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
           </tr>
         </table>
       </div>
     </div>
  </div>
</div>
<div id="right-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page342.html"><img src="images/next_big.png" width="90" height="80" /></a></p>
</div>


</div>

</body>
</html>
